Effects of the anti-platelet aggregation drug dilazep on cognitive function in Dahl salt-sensitive rats

Hypertension Research

Volumn 26, Issue 2, 2003, Pages 185-191

  Numabe, Atsushi ^d   Ara, Nusrat ^a   Hakamada Taguchi, Rie ^b   Suzuki, Noriko ^d   Hirawa, Nobuhito ^c   Kawabata, Yukari ^b   Negoro, Toshiyuki ^b   Nagata, Taiji ^b   Goto, Atsuo ^b   Toyo Oka, Teruhiko ^b   Fujita, Toshiro ^b   Uehara, Yoshio ^b  

^a University Rawalpindi   (Pakistan)

^b UNIVERSITY OF TOKYO   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Blood pressure; Cognition; Dahl rats; Dilazep; Glomerulosclerosis

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; DILAZEP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DRINKING WATER; NITRENDIPINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; BRAIN CAPILLARY; BRAIN FUNCTION; BRAIN NERVE CELL; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; GLOMERULOPATHY; HIPPOCAMPUS; KIDNEY INJURY; LATENT PERIOD; LONG TERM CARE; LOW DRUG DOSE; NONHUMAN; PASSIVE AVOIDANCE; RAT; RAT STRAIN; REGULATORY MECHANISM; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE;

ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BLOOD PRESSURE; COGNITION; DIET, SODIUM-RESTRICTED; DILAZEP; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; KIDNEY; PLATELET AGGREGATION INHIBITORS; RATS; RATS, INBRED DAHL; SODIUM CHLORIDE, DIETARY; VASODILATOR AGENTS;

EID: 0037299219     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.26.185     Document Type: Article

References (22)

1. Staessen JA, Fagard R, Thijs L, et al: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757-764.
2. Leonetti G, Dalvetti A: Effects of cilazapril and nitrendipine on blood pressure, mood, sleep, and cognitive function in elderly hypertensive patients: an Italian Multicenter Study. J Cardiovasc Pharmacol 1994; 24 (Suppl 3): S73-S77.
3. Hakamada-Taguchi R, Uehara Y, Negoro H, Toyo-oka T: The relationship between lower systolic blood pressure and cognitive function in normotensive, middle-aged healthy women. Hypertens Res 2002; 25: 565-569.
4. Hirawa N, Uehara Y, Kawabata Y, et al: Long-term inhibition of renin-angiotensin system sustains memory function in aged Dahl rats. Hypertension 1999; 34: 496-502.
5. Hoque AN, Hoque N, Hara A, Hashizume H, Ichihara K, Abiko Y: Cardioprotective effect of K-7259, a novel dilazep derivative, against ischemia-reperfusion damage in isolated, working rat hearts. Jpn J Pharmacol 1997; 73: 365-369.
6. Ozaki Y, Jinnai Y, Yatomi Y, Tawata M, Onaya T, Kume S: Effects of dilazep on platelet functions and volume change in patients with diabetes mellitus. Arzneimittelforschung 1993; 43: 536-539.
7. Asanuma A, Yamauchi Y, Koga T, Katayama I: Suppression of age-related changes in mouse hippocampal CA3 nerve cells by a free radical scavenger. Mech Ageing Dev 1995; 83: 55-64.
8. Hayashi T, Kaneko S, Thang NT, Shou I, Shirato I, Tomino Y: Effect of dilazep hydrochloride on the immunohistopathology of IgA nephropathy in ddY mice. Nephron 2000; 86: 327-332.
9. Gohda T, Makita Y, Shike T, et al: Effect of dilazep hydrochloride, an antiplatelet agent, on the proliferation of cultured mouse glomerular mesangial cells. Nephron 2000; 84: 90-91.
10. Sakumura T, Fujii Z, Umemoto S, et al: Dilazep, a nucleoside transporter inhibitor, modulates cell cycle progression and DNA synthesis in rat mesangial cells in vitro. Cell Prolif 2000; 33: 19-28.
11. Yamauchi Y, Ikuta J, Shimizu S, Nakamura M: Effect of dilazep dihydrochloride on ischemia and reperfusion-induced cerebral injury in spontaneously hypertensive rats. Nippon Yakurigaku Zasshi 1990; 95: 239-246 (in Japanese).
12. Valori VM, Leone G, Traisci G, Bizzi B: A comparative study on the effect of dilazep and dipyridamole on some platelet functions. Arzneimittelforschung 1982; 32: 403-405.
13. Hirawa N, Uehara Y, Kawabata Y, et al: Subpressor dose of angiotensin II increases susceptibility to the haemodynamic injury of blood pressure in Dahl salt-sensitive rats. J Hypertens 1995; 13: 81-90.
14. Hirawa N, Uehara Y, Kawabata Y, et al: Mechanistic analysis of renal protection by angiotensin converting enzyme inhibitor in Dahl salt-sensitive rats. J Hypertens 1994; 12: 909-918.
15. Braszko JJ, Wisniewski K: Effects of angiotensin II and saralasin on motor activity and the passive avoidance behavior of rats. Peptides 1988; 9: 475-479.
16. Tadokoro S, Kuribara H, Hayashi H: Methodological problems on learning and memory tests in rodents from view points of behavioral toxicology, in Fujii T and Adams PM (eds): Functional Teratogenesis; Functional Effects on the Offspring after Parenteral Drug Exposure. Tokyo, Teikyo University Press, 1987, pp 53-70.
17. Uehara Y, Kawabata Y, Shirahase H, et al: Radical scavengers of indapamide and renal protection in Dahl salt sensitive rats. Hypertens Res 1992; 15: 17-26.
18. Zola-Morgans, Squire LR, Amaral DG: Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J Neurosci 1986; 6: 2950-2967.
19. Tabuchi E, Endo S, Ono T, Nishijo H, Kuza S, Kogure K: Hippocampal neuronal damage after transient forebrain ischemia in monkeys. Brain Res Bull 1992; 29: 685-690.
20. Sakanaka M, Wen TC, Matsuda S, Morishita E, Nagao M, Sasaki R: In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A 1998; 95: 4635-4640.
21. Testa MA, Turner RP, Simonson DC, Krafcik MB, Calvo C, Luque-Otero M, the Nifedipine GITS Study Group: Quality of life and calcium channel blockade with nifedipine GITS versus amlodipine in hypertensive patients in Spain. J Hypertens 1998; 16: 1839-1847.
22. Morris R: Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984; 11: 47-60.